Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00825994 · ClinicalTrials.gov registry record · NA
Omega-3 for Peri- and Postmenopausal Depression
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT00825994: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00825994 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00825994, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if an eight-week intervention with omega-3 fatty acids significantly reduces depressive symptoms in symptomatic peri- and postmenopausal women. We hypothesize that an eight-week trial with omega-3 fatty acids promotes significant improvement in depression symptoms in peri- and postmenopausal women.
Interventions
- DRUG Omega-3 Fatty Acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00825994
The ClinicalTrials.gov registry entry for NCT00825994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omega-3 Fatty Acids is the first listed.
NCT00825994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00825994 about?
NCT00825994 is a clinical study titled "Omega-3 for Peri- and Postmenopausal Depression". The purpose of this study is to determine if an eight-week intervention with omega-3 fatty acids significantly reduces depressive symptoms in symptomatic peri- and postmenopausal women. We hypothesize that an eight-week trial with omega-3 fatty acids promotes significant improvement in depression sy...
What is the current status of trial NCT00825994?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2008-11. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00825994?
The interventions under investigation include: Omega-3 Fatty Acids (DRUG).
Who is sponsoring clinical trial NCT00825994?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.